DK77588A - Prostaglandin e1-derivater og farmaceutiske praeparater, der indeholder dem - Google Patents

Prostaglandin e1-derivater og farmaceutiske praeparater, der indeholder dem

Info

Publication number
DK77588A
DK77588A DK077588A DK77588A DK77588A DK 77588 A DK77588 A DK 77588A DK 077588 A DK077588 A DK 077588A DK 77588 A DK77588 A DK 77588A DK 77588 A DK77588 A DK 77588A
Authority
DK
Denmark
Prior art keywords
prostaglandin
derivatives
pharmaceutical preparations
preparations containing
compounds
Prior art date
Application number
DK077588A
Other languages
English (en)
Other versions
DK77588D0 (da
DK173552B1 (da
Inventor
Juergen C Froelich
Herbert Bippi
Original Assignee
Juergen C Froelich
Herbert Bippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juergen C Froelich, Herbert Bippi filed Critical Juergen C Froelich
Publication of DK77588D0 publication Critical patent/DK77588D0/da
Publication of DK77588A publication Critical patent/DK77588A/da
Application granted granted Critical
Publication of DK173552B1 publication Critical patent/DK173552B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198800775A 1987-02-16 1988-02-15 Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift DK173552B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873704825 DE3704825A1 (de) 1987-02-16 1987-02-16 Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung
DE3704825 1987-02-16

Publications (3)

Publication Number Publication Date
DK77588D0 DK77588D0 (da) 1988-02-15
DK77588A true DK77588A (da) 1988-08-17
DK173552B1 DK173552B1 (da) 2001-02-26

Family

ID=6321070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198800775A DK173552B1 (da) 1987-02-16 1988-02-15 Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift

Country Status (11)

Country Link
EP (1) EP0292643B1 (da)
JP (1) JPS63246331A (da)
AT (1) ATE80616T1 (da)
AU (2) AU623336B2 (da)
CA (1) CA1327359C (da)
DE (2) DE3704825A1 (da)
DK (1) DK173552B1 (da)
ES (1) ES2043696T3 (da)
GR (1) GR3005743T3 (da)
HU (1) HU199687B (da)
ZA (1) ZA881053B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2939569A (en) * 1957-10-16 1960-06-07 Gay W Roach Cotton weighing machine

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017806A1 (fr) * 1993-02-03 1994-08-18 Teijin Limited Composition de preparation dermatologique contenant de la prostacycline comme principe actif
CA2133435A1 (en) * 1993-02-03 1994-08-04 Atsuo Hazato External skin treatment agent composition containing isocarbacyclins as active ingredient
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
AU2004227853A1 (en) * 2003-04-02 2004-10-21 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali
WO2012139033A1 (en) * 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
US8865685B2 (en) 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
ITRM20120036A1 (it) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735005A (en) * 1970-08-19 1973-05-22 Alza Corp Method for preparing a viable platelet concentrate
US4205178A (en) * 1976-12-30 1980-05-27 The Upjohn Company 6-Keto prostaglandin E-type compounds
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2939569A (en) * 1957-10-16 1960-06-07 Gay W Roach Cotton weighing machine

Also Published As

Publication number Publication date
JPS63246331A (ja) 1988-10-13
DE3704825A1 (de) 1988-08-25
DE3874610D1 (da) 1992-10-22
DK77588D0 (da) 1988-02-15
AU623336B2 (en) 1992-05-14
EP0292643B1 (de) 1992-09-16
AU1518492A (en) 1992-06-25
CA1327359C (en) 1994-03-01
DK173552B1 (da) 2001-02-26
AU1176688A (en) 1988-08-18
AU649130B2 (en) 1994-05-12
EP0292643A1 (de) 1988-11-30
ZA881053B (en) 1988-08-12
HU199687B (en) 1990-03-28
GR3005743T3 (da) 1993-06-07
HUT46224A (en) 1988-10-28
ES2043696T3 (es) 1994-01-01
ATE80616T1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
PT83872A (de) Arzneimittel
DK365488D0 (da) Nye bensimidazolderivater, fremgangsmaade til fremstilling deraf og et farmaceutisk praeparat indeholdende dem
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
DK77588A (da) Prostaglandin e1-derivater og farmaceutiske praeparater, der indeholder dem
DK164907C (da) Piperazinderivater, deres fremstilling og farmaceutiske praeparater indeholdende dem
DK438788D0 (da) Alkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende dem
DK258187D0 (da) 1-(hydroxystyryl)-5h-2,3-benzodiazepinderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende dem
DK504986D0 (da) 7-acylbenzoxazinoner og deres derivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
NO883047D0 (no) Substituerte benzimidazoler, fremgangsmaate til deres fremstilling, farmasoeytise tilberedninger inneholdende dem og deres anvendelse.
FI883392A7 (fi) Silybiinin liukoiset johdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset.
DK425384D0 (da) Acylindol-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater som indeholder dem
DK258287A (da) 3-(hydroxymetyl)-isoquinolinderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende dem
DK265788D0 (da) Hydrazinderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater der indeholder dem
ATE55254T1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
ATE67674T1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
NO881280D0 (no) Nye tieno-imidazo(2,1-b)tiazolderivater, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder dem.
ATE50494T1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
DK176981A (da) Pyrrol(3,4-c)kinolinderivater,fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
ES556799A0 (es) Procedimiento de produccion de preparados farmaceuticos conteniendo al menos una materia activa farmaceutica,especialmente una materia activa insoluble o dificil o lentamente soluble.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK